BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21152452)

  • 1. Targeting amyloid precursor protein secretases: Alzheimer's disease and beyond.
    Ganjei JK
    Drug News Perspect; 2010 Nov; 23(9):573-84. PubMed ID: 21152452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in Alzheimer's disease drug discovery: an update.
    Williams M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of new therapeutics for Alzheimer's disease.
    Carter MD; Simms GA; Weaver DF
    Clin Pharmacol Ther; 2010 Oct; 88(4):475-86. PubMed ID: 20811351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of amyloid beta peptide 42 in Alzheimer's disease.
    Findeis MA
    Pharmacol Ther; 2007 Nov; 116(2):266-86. PubMed ID: 17716740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alzheimer's disease: therapeutic perspectives].
    Dubois B; De Souza L; Allali G; Kalafat M; Sarazin M
    Bull Acad Natl Med; 2008 Feb; 192(2):333-42; discussion 343-4. PubMed ID: 18819687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretase inhibitors and modulators for Alzheimer's disease treatment.
    Tomita T
    Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and development of BACE-1 inhibitors.
    Cumming JN; Iserloh U; Kennedy ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):536-56. PubMed ID: 15338962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the tangled brain of Alzheimer's.
    Wolfson W
    Chem Biol; 2008 Feb; 15(2):89-90. PubMed ID: 18291309
    [No Abstract]   [Full Text] [Related]  

  • 10. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.
    Lahiri DK; Chen D; Maloney B; Holloway HW; Yu QS; Utsuki T; Giordano T; Sambamurti K; Greig NH
    J Pharmacol Exp Ther; 2007 Jan; 320(1):386-96. PubMed ID: 17003227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta- and gamma-secretases].
    Iwatsubo T
    Rinsho Shinkeigaku; 2006 Nov; 46(11):925-6. PubMed ID: 17432221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-secretase: a complex target for Alzheimer's disease.
    Lundkvist J; Näslund J
    Curr Opin Pharmacol; 2007 Feb; 7(1):112-8. PubMed ID: 17169612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting.
    Rajendran L; Schneider A; Schlechtingen G; Weidlich S; Ries J; Braxmeier T; Schwille P; Schulz JB; Schroeder C; Simons M; Jennings G; Knölker HJ; Simons K
    Science; 2008 Apr; 320(5875):520-3. PubMed ID: 18436784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond amyloid: the next generation of Alzheimer's disease therapeutics.
    Seabrook GR; Ray WJ; Shearman M; Hutton M
    Mol Interv; 2007 Oct; 7(5):261-70. PubMed ID: 17932415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
    Saxena U
    Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential for BACE1 inhibitors in the treatment of Alzheimer's disease.
    Hussain I
    IDrugs; 2004 Jul; 7(7):653-8. PubMed ID: 15243867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid inhibitors and Alzheimer's disease.
    Xia W
    Curr Opin Investig Drugs; 2003 Jan; 4(1):55-9. PubMed ID: 12625030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs targeting Alzheimer's disease: some things old and some things new.
    Michaelis ML
    J Pharmacol Exp Ther; 2003 Mar; 304(3):897-904. PubMed ID: 12604663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease.
    Rossner S; Sastre M; Bourne K; Lichtenthaler SF
    Prog Neurobiol; 2006 Jun; 79(2):95-111. PubMed ID: 16904810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.